Abstract

A tenet of F. Macfarlane Burnet's clonal selection theory is that a potential antibody-forming cell is genetically preprogrammed to synthesize antibodies of a single specificity. Gus Nossal, one of Burnet's colleagues, proposed that the theory could be disproved if a single cell produced antibodies of different specificities. Nossal, along with Joshua Lederberg, designed an experiment using a technique allowing them to detect the specificity of antibodies produced by individual antibody-producing cells. This microdrop technique, used with several different antigens, consistently demonstrated that virtually all cells tested produced antibodies of a single specificity; this led to the concept of one cell:one antibody. Support for this conclusion came from other studies, including immunofluorescent observations of antibody-forming cells and identification of the cell surface receptors on B lymphocytes. In the clinic, patients with multiple myeloma, a disease characterized by the appearance in serum of a large amount of homogeneous immunoglobulin, possess malignantly transformed cells, all of which arise from a single precursor and synthesize a single immunoglobulin molecule. Production of antibody of a single specificity by plasma cells allowed development of monoclonal antibodies that have greatly enhanced the therapeutic and laboratory choices available to investigators.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.